Compare MANE & RDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MANE | RDN |
|---|---|---|
| Founded | 2019 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.9B |
| IPO Year | 2026 | 2008 |
| Metric | MANE | RDN |
|---|---|---|
| Price | $103.89 | $35.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $83.33 | $40.67 |
| AVG Volume (30 Days) | 520.8K | ★ 772.6K |
| Earning Date | 03-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.73% |
| EPS Growth | N/A | ★ 5.61 |
| EPS | N/A | ★ 1.74 |
| Revenue | N/A | ★ $1,197,084,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.66 |
| P/E Ratio | ★ N/A | $20.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $36.26 | $31.50 |
| 52 Week High | $131.24 | $41.05 |
| Indicator | MANE | RDN |
|---|---|---|
| Relative Strength Index (RSI) | 48.15 | 42.01 |
| Support Level | $94.68 | $31.87 |
| Resistance Level | $116.86 | $37.34 |
| Average True Range (ATR) | 4.66 | 0.62 |
| MACD | 0.26 | -0.03 |
| Stochastic Oscillator | 66.45 | 20.51 |
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one reportable segment, Mortgage Insurance, which primarily derives its revenue by providing private mortgage insurance on residential first-lien mortgage loans to mortgage lending institutions and mortgage credit investors.